Over the past thirty years, NIH has initiated programs to increase diversity within the scientific workforce. The coming year will mark the beginning of renewed efforts to enhance our current activities, and to identify other opportunities to address diversity in the scientific research enterprise.
December 3, Acting Director, NIH Raynard S. Kington, M.D., Ph.D., announced the appointment of Linda S. Birnbaum, Ph.D., D.A.B.T., A.T.S., as Director of the National Institute of Environmental Health Sciences (NIEHS).
CSR changed the chartered study section descriptions to make them more transparent and reflective of the types of applications actually reviewed by CSR study sections.
The NIH will begin implementing changes in the Fiscal Year 2010 funding cycle. Investigators submitting applications in January 2009 and later should be aware of these new policies.
Transition to Adobe officially began on December 5, 2008, when NIH updated more than 500 active Funding Opportunity Announcements (FOAs) with Adobe-based application packages and closed their PureEdge predecessors. The new Adobe forms are required for submission for most receipt dates in January and beyond.
What is a NIH Regional Seminar? Held twice a year, the NIH Regional Seminars are intended to help demystify the application and review process, clarify federal regulations and policies, and highlight current areas of special interest or concern. NIH policy … Continue reading
The Center for Cancer Research and the Division of Cancer Prevention at the National Cancer Institute will present the symposium Molecular Targets for Cancer Prevention, February 4 and 5, 2009 at NIH Natcher Conference Center, Bethesda, Maryland. Evidence from both … Continue reading
For many months, the NIH has been explaining the new Research, Condition, and Disease Categorization (RCDC) project and how it will change the way we report on the research we fund. RCDC is part of a wider NIH effort to … Continue reading
In this time of rapid global change, the NIH is newly energized in its mission of improving health worldwide, I eagerly look forward to supporting the Agency in this effort as it further strengthens its foundations for the future.
At the request of the Subcommittee on Health, Committee on Energy and Commerce, United States House of Representatives, NIH Acting Director Raynard S. Kington, M.D., Ph.D., testified at a hearing entitled “Treatments for an Ailing Economy:Protecting Health Care Coverage and Investing in Biomedical Research,” held on November 13, 2008. (more…) Continue reading